Company India Globalization Capital, Inc. Nyse
Equities
US45408X1000
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Life Sciences
87.8
%
| 1 | 87.6 % | 1 | 87.8 % | +47.99% |
Infrastructure
12.2
%
| 0 | 12.4 % | 0 | 12.2 % | +45.13% |
Sales per region
USD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
United States
87.7
%
| 1 | 85.3 % | 1 | 87.7 % | +51.74% |
India
12.2
%
| 0 | 12.4 % | 0 | 12.2 % | +45.13% |
Colombia
0.1
%
| 0 | 2.3 % | 0 | 0.1 % | -90.48% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 05-04-28 |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 18-05-08 |
Chief Tech/Sci/R&D Officer | - | - | |
Jagadeesh Rao
CTO | Chief Tech/Sci/R&D Officer | 57 | 17-09-30 |
Rohit Goel
AUD | Comptroller/Controller/Auditor | 30 | 17-09-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 05-04-28 |
Richard Prins
CHM | Chairman | 67 | 07-04-30 |
Director/Board Member | 79 | 22-01-17 | |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 18-05-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 75,636,419 | 69,447,419 ( 91.82 %) | 0 | 91.82 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- IGC Stock
- Stock
- Company India Globalization Capital, Inc.